Myocarditis following COVID-19 mRNA (mRNA-1273) vaccination.
Covid‐19
mRNA‐1273 vaccine
myocarditis
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
08
08
2021
revised:
24
02
2022
accepted:
28
03
2022
entrez:
22
4
2022
pubmed:
23
4
2022
medline:
23
4
2022
Statut:
epublish
Résumé
In this case report, we presented a case of myocarditis as a rare complication that developed after Covid mRNA-1273 vaccine. Cases of post-vaccine myocarditis usually progress with mild symptoms. However, it should be a situation that healthcare workers should keep in mind, that myocarditis may develop after vaccination.
Identifiants
pubmed: 35449778
doi: 10.1002/ccr3.5741
pii: CCR35741
pmc: PMC9014704
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e05741Informations de copyright
© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
None declared.
Références
Int J Cardiol. 2018 Dec 15;273:183-186
pubmed: 30236504
Circulation. 2021 Aug 10;144(6):506-508
pubmed: 34133884
Heart Rhythm. 2020 Sep;17(9):1463-1471
pubmed: 32387246
Clin Case Rep. 2022 Apr 18;10(4):e05741
pubmed: 35449778
Nat Rev Drug Discov. 2018 Apr;17(4):261-279
pubmed: 29326426
Vaccine. 2021 Jun 29;39(29):3790-3793
pubmed: 34092429
Radiol Case Rep. 2021 Aug;16(8):2142-2145
pubmed: 34025885
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d
pubmed: 23824828
N Engl J Med. 2009 Apr 9;360(15):1526-38
pubmed: 19357408
N Engl J Med. 2021 Dec 2;385(23):2140-2149
pubmed: 34614328